pargyline has been researched along with Nutritional Disorders in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Randt, CT | 1 |
| Blizard, DA | 1 |
| Friedman, E | 1 |
| Cooper, BR | 1 |
| Breese, GR | 1 |
1 review available for pargyline and Nutritional Disorders
| Article | Year |
|---|---|
Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Topics: Amphetamine; Animals; Behavior, Animal; Body Temperature Regulation; Body Weight; Brain; Dihydroxyph | 1974 |
1 other study available for pargyline and Nutritional Disorders
| Article | Year |
|---|---|
Early life undernutrition and aggression in two mouse strains.
Topics: Aggression; Animals; Animals, Newborn; Brain; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mal | 1975 |